Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Change in Accured Expenses (2018 - 2025)

Zevra Therapeutics' Change in Accured Expenses history spans 11 years, with the latest figure at $412000.0 for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 94.11% year-over-year to $412000.0; the TTM value through Dec 2025 reached -$15.6 million, down 333.21%, while the annual FY2025 figure was -$15.6 million, 333.21% down from the prior year.
  • Change in Accured Expenses reached $412000.0 in Q4 2025 per ZVRA's latest filing, up from -$4.7 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $7.0 million in Q4 2024 to a low of -$7.3 million in Q1 2024.
  • Average Change in Accured Expenses over 5 years is -$301850.0, with a median of -$35500.0 recorded in 2021.
  • Peak YoY movement for Change in Accured Expenses: crashed 410.58% in 2021, then soared 889.3% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at $778000.0 in 2021, then soared by 140.23% to $1.9 million in 2022, then skyrocketed by 206.58% to $5.7 million in 2023, then rose by 22.02% to $7.0 million in 2024, then tumbled by 94.11% to $412000.0 in 2025.
  • Per Business Quant, the three most recent readings for ZVRA's Change in Accured Expenses are $412000.0 (Q4 2025), -$4.7 million (Q3 2025), and -$4.0 million (Q2 2025).